Expresses the sense of the Congress that any national health care reform legislation should cover syringes for those individuals with diabetes who require the administration of insulin by syringe.
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the House Committee on Ways and Means.
Referred to the Subcommittee on Health.
Sponsor introductory remarks on measure. (CR H2577)
Referred to the Subcommittee on Health and the Environment.
Sponsor introductory remarks on measure. (CR H6555)
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line